the role of the medical review officer n.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
The Role of the Medical Review Officer PowerPoint Presentation
Download Presentation
The Role of the Medical Review Officer

Loading in 2 Seconds...

play fullscreen
1 / 42

The Role of the Medical Review Officer - PowerPoint PPT Presentation


  • 467 Views
  • Uploaded on

The Role of the Medical Review Officer. Michelle Alexander, MD. Random Drug and Alcohol Testing Rates 2008. Drug testing rate was reduced from 50% to 25% in 2007 Alcohol testing rate remains the same at 10%. MRO’s Role. Independent and Impartial Advocate

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

The Role of the Medical Review Officer


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
random drug and alcohol testing rates 2008
Random Drug and Alcohol Testing Rates 2008
  • Drug testing rate was reduced from 50% to 25% in 2007
  • Alcohol testing rate remains the same at 10%
mro s role
MRO’s Role
  • Independent and Impartial Advocate
  • Gatekeeper for the integrity and accuracy of the drug testing process
  • Quality assurance review
  • Timely Flow
  • Confidentiality
qualifications
Qualifications
  • Licensed physician
  • Basic knowledge of SA disorders
  • Qualification training
  • Certification examination
  • Continuing education
confidentiality
Confidentiality
  • Results released only to authorized persons or parties (DER, SAP, DOT, C/TPA etc.)
  • Results released only after verification
  • Quantitative results are only released to the SAP and employee
  • Confidential retention of records
relationships
Relationships
  • Laboratory
  • Designated Employer Representative (DER)
  • Collectors
  • Substance Abuse Professionals (SAP)
  • Third Party Administrators (TPA)
mro functions
MRO Functions
  • Review of negative tests

Personal review of 5% of all CCF and all results that require a corrective action quarterly up to 500 tests

negative tests
Negative tests
  • Immunoassay results are below the initial test cutoffs or
  • GC/MS results below the confirmatory cutoffs, and
  • Specimen validity test results in the acceptable range.
mro functions1
MRO Functions
  • Review of all laboratory confirmed drug tests:
  • Positives
  • Adulterated
  • Substituted
  • Invalid
mro miranda
MRO Miranda
  • Explain at the start of the interview that the information provided to you in the course of determining if a legitimate medical explanation exists can be shared with the employer, DOT and other agencies. In addition, if such information affects workplace safety or indicates that the employee is otherwise not medically qualified the employer can be notified.
positive drug tests
Positive Drug Tests
  • Direct contact with the employee or candidate
  • Verify the test as negative, positive, or test cancelled
cocaine positive
Cocaine Positive
  • 2nd most common drug of abuse for workplace testing programs
  • Medical uses uncommon (topical, nasal and dental)
  • Used in combination with many other drugs
  • Snorted, inhaled, injected and used orally
urine
Urine
  • Cocaine is metabolized to benzoylecgonine
  • Rapid excretion within in as little as 1-3 days
slide14
Hair
  • Test for benzoylecgonine, cocaethylene, and norcocaine
  • Hair washing is performed to eliminate issues of passive exposure
  • Some evidence of metabolite must be present to confirm positives
  • Single use is unlikely to result in a positive test
  • Hair color
marijuana
Marijuana
  • Cannabis sativa plant
  • Cannabinoid
  • THC
  • Medical uses Marinol

Schedule III drug

Approved for treatment of nausea, appetite stimulant

marijuana decriminalization
Marijuana Decriminalization
  • 11 states- Alaska, Arizona, California, Colorado, Hawaii, Maine, Montana, Nevada, Oregon, Vermont, and Washington
  • Does not establish system for providing marijuana
  • Federal law it remains illegal
marijuana effects
Marijuana Effects
  • Schedule I drug
  • Hallucinogen
  • Drowsiness
  • Impaired concentration and perceptual skills
  • Withdrawal- nausea, insomnia, irritability, anxiety
urine1
Urine
  • About 30% metabolized to THCA
  • Urine positive for 1-21 days (infrequent vs. frequent use)
slide19
Hair
  • Lower cutoffs
  • Single use is unlikely to result in a positive test
oral fluid
Oral Fluid
  • Target parent drug THC
  • Deposited in the oral cavity during use
  • Concentration rise quickly and fall rapidly in the first hour
  • Cutoff are recommended very low
amphetamines
Amphetamines
  • Amphetamine
  • Methamphetamine,
  • Methylenedioxyamphetamine (MDA) and
  • Methylenedioxymethamphetamine (MDMA).
opiate positive
Opiate Positive
  • 6-AM verify positive

In the absence of 6-AM

  • At 15,000 ng/ml or > verify positive unless legitimate medical explanation
  • At levels < 15,000 ng/ml determine if clinical evidence exists
adulterated or substituted tests
Adulterated or Substituted Tests
  • Direct contact with the employee or candidate
  • Determine the factual information from the laboratory
  • Verify the test as refusal to test
dilute samples
Dilute samples
  • Creatinine > or equal to 2 and < 20mg/dl and
  • Specific gravity > 1.0010 but < 1.0030
substituted sample
Substituted sample
  • Creatinine < 2 mg/dl and
  • Specific gravity < or equal to 1.0010

or > or equal to 1.0200

adulterated samples
Adulterated samples
  • pH < 3 or > or equal to 11
  • Nitrite concentration > or equal to 500 mcg/ml
  • An exogenous substance is present
adulterated or substituted tests1
Adulterated or Substituted Tests
  • Direct contact with the employee or candidate
  • Determine the factual information from the laboratory
  • Verify the test as refusal to test
common adulterants
Common Adulterants
  • Nitrites (Klear, Whizzies)
  • Alkylephoxysulfonate (Mary Jane’s Super Clean)
  • NaCl (table salt)
  • UrinAid (Glutaraldehyde)
  • Urine Luck (Pyridine)
invalid specimens
Invalid specimens

Creatinine concentration & specific gravity results are discrepant:

  • Creatinine < 2 mg/dl & specific gravity > or equal to 1.0010 and < 1.0200
  • Creatinine > or equal to 2mg/dl &

specific gravity < or equal to 1.0010

invalid specimens cont d
Invalid specimens cont’d

pH outside acceptable range

  • pH is > or equal to 3 and < 4.5; or
  • pH > or equal to 9 and< 11

Nitrite present

  • Nitrite > or equal to 200mcg/ml
mro verification without interview
MRO Verification without Interview
  • Employee expressly declines to speak with you.
  • After 3 unsuccessful attempts to contact the employee (both day and evening) over a 24 hour period and the DER has made such contact and more than 72 hrs have elapsed.
  • Neither you or the DER has been able to make contact with the employee and more than 10 days have elapsed
common errors
Common Errors
  • Correctable

Collector

Donor ID number omitted or incorrect on CCF

(unless refusal)

Collectors signature missing certification statement

Incomplete COC block (at least 2 signatures and dates, shipping entry)

common errors1
Common Errors

Correctable

  • Donor signature missing from certification statement (unless refusal)
  • Using incorrect CCF (DOT vs. non DOT)

Lab

  • Certifying scientist signature omitted on positives
fatal flaws
Fatal Flaws
  • Specimen ID missing from specimen bottle or fails to match
  • Volume less than 30 ml
  • Specimen seal is broken or shows evidence of tampering
  • Specimen shows obvious adulteration

(color, foreign objects, unusual odor, etc)

blind samples
Blind Samples
  • Submitted with donor samples
  • These samples should be verified:

Negative

Drug Positive

Adulterated

Substituted

shy bladder collection
Shy Bladder Collection
  • After the first failed attempt of less than 45 cc urine (split)
  • 3 hour window
  • Instructed to drink 40 oz of water over the 3 hours (~8 oz of water/30 minutes)
failure to provide sufficient sample for testing
Failure to provide sufficient sample for testing
  • Obtain a detailed medical history ASAP.
  • Refer to an appropriate trained physician acceptable to you.
  • Consider information provided to you by this physician and make your determination.
other samples for testing
Other samples for testing

Not currently approved under 49CFR 655

  • Oral Fluid
  • Sweat
  • Hair
recommendations
Recommendations
  • Education!
  • Collectors and DERs
  • Physicians used to make medical determinations (shy bladder, lung/refusals)
preventive measures
Preventive measures
  • Routine
  • Forms
  • MRO checklist
interesting websites
Interesting websites
  • http://www.passyourdrugtest.com/
  • http://www.cleartest.com/
  • http://www.detoks.com/